Evidence map›Paper›PMID 40001076›Full record

ArticleBMC health services research2025

Development of a self-management behavior assessment scale for liver cancer patients from ethnic minorities.

Beijia Liu, Jun Chen, Xue Zhao, Qian Gui, Ying Lin, Bingrong He, Lixia Zhang, Lijuan Feng, Yin Zhang, Anyun Yu and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC health services research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Beijia Liu *Department of Comprehensive Ward, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Jun Chen *Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China.
Xue ZhaoDepartment of Comprehensive Ward, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Qian GuiDepartment of Comprehensive Ward, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Ying LinDepartment of Comprehensive Ward, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Bingrong HeDepartment of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China.
Lixia ZhangDepartment of Hepatopancreatobiliary Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China.
Lijuan FengDepartment of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China.
Yin ZhangDepartment of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China.
Anyun YuDepartment of Nursing, The First People's Hospital of Liangshan Yi Autonomous Prefecture, Xichang, China.
Meiling LiuDepartment of Hepatopancreatobiliary Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China.
Xiaoli TangDepartment of Comprehensive Ward, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China. 1585470513@qq.com.
Guiyu HuangDepartment of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China. huangguiyu88128@163.com.

Funding

the Science and Technology Department of Sichuan Province 23KPZP0101
6 · The paper itself

Abstract

backgroundLiver cancer poses significant health challenges worldwide, particularly for ethnic minority populations, who often face barriers such as cultural differences, limited health literacy, and inadequate access to healthcare, contributing to poorer self-management and treatment outcomes. Existing self-management tools do not adequately address the unique needs of ethnic minority liver cancer patients, necessitating the development of a culturally tailored assessment scale.

methodsGrounded in the Health Belief Model, this study developed a self-management behavior assessment scale specifically for ethnic minority liver cancer patients. The scale was constructed using a comprehensive literature review, semi-structured qualitative interviews with 11 ethnic minority liver cancer patients, and two rounds of expert consultation via the Delphi method. The initial item pool was refined through expert input to ensure relevance and cultural sensitivity.

resultsThrough literature review and semi-structured qualitative interviews with 11 ethnic minority liver cancer patients, four key dimensions were identified: health behavior management, disease perception and cognition, psychological and emotional regulation, and information acquisition and decision-making participation. These dimensions and items were further refined through two rounds of expert consultation using the Delphi method, ensuring the scale's cultural relevance and content validity. As a result, a self-management behavior assessment scale was developed, consisting of four dimensions and 31 items tailored to the specific needs of ethnic minority liver cancer patients.

conclusionThis newly developed scale provides a culturally sensitive tool to assess self-management behaviors in ethnic minority liver cancer patients. It has the potential to enhance patient care by identifying culturally specific barriers to effective self-management. Further research is needed to validate the scale's reliability and applicability in broader patient populations.

Indexed as

EthnicityHealth BehaviorLiver NeoplasmsMinority GroupsSelf-ManagementAdultAgedDelphi TechniqueFemaleHumansInterviews as TopicMaleMiddle AgedQualitative ResearchSurveys and QuestionnairesAssessmentEthnic minorityLiver neoplasmsSelf-management

Identifiers

PMID40001076
PMCPMC11863450

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.